IRF1 and neoplasm: Further IHC analysis showed that the tumours in the Lv-IRF-1 group treated with Dox exhibited significantly increased IRF-1 expression and significantly reduced β-catenin and C-Myc levels compared with those in the Lv-IRF-1 and Lv-Null + Dox groups (Fig. 7e, f).